update on tirzepatide $125/mo Compounded (vs $1,069 Mounjaro) FDA approval for Zepbound (tirzepatide)

There is no clear scientific support for pre-workout dosing as a protective strategy

High-risk breeds include Golden Retrievers, Dobermanns, Boxers, and Cocker Spaniels

Research data show that tirzepatide, through its dual action on GIP and GLP-1, effectively improves insulin sensitivity and significantly reduces body weight, providing patients with a comprehensive health solution

Why it matters Vascular dementia is the second most common dementia, affecting 2.7 million Americans

Tirzepatide is unique because it's a dual-agonist, targeting both GLP-1 and GIP receptors, which our experience shows can lead to even more significant weight loss for some individuals